Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Quotazioni in diretta
| Data | Ora | Fonte | Titolo |
|---|---|---|---|
| 14/11/2024 | 14:00 | GLOBE | Entero Therapeutics CEO James Sapirstein to Moderate the.. |
| 13/11/2024 | 13:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13/11/2024 | 13:00 | EDGAR2 | Form 8-K - Current report |
| 13/11/2024 | 13:00 | GLOBE | Entero Therapeutics Announces Proposed Reverse Merger with.. |
| 21/10/2024 | 13:31 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/10/2024 | 23:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/9/2024 | 13:00 | GLOBE | Entero Therapeutics Signs Letter of Intent to License and.. |
| 23/8/2024 | 23:00 | GLOBE | Entero Therapeutics, Inc. Receives Nasdaq Notification.. |
| 31/7/2024 | 13:00 | GLOBE | Entero Therapeutics’ Chairman and CEO James Sapirstein.. |
| 27/6/2024 | 12:00 | GLOBE | Entero Therapeutics Announces Peer-Reviewed Publication.. |
| 22/5/2024 | 13:00 | GLOBE | Entero Therapeutics to Present Corporate Update at 2024 BIO.. |
| 20/5/2024 | 13:00 | GLOBE | Entero Therapeutics Presents Two Posters on Celiac Disease.. |
| Apertura: 0,4507 | Min: 0,4124 | Max: 0,477025 |
| Chiusura: 0,4652 |
|
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni |
|
ADVFN Network
|
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
